Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8168800
Aβ-binding small molecules
granted -
US 8168200
Vaccine against african horse sickness virus
granted -
US 8168391
Method for modulating insulin production
granted -
US 8168591
Compositions and methods related to anti-FGF agents
granted -
US 8163294
Growth regulatable recombinant BCG compositions
granted -
US 8163893
Pseudotyped retroviral vectors and methods of use thereof
granted -
US 8163548
Recombinant bicistronic flaviviruses and methods of use thereof
granted -
US 8162918
Gels with predetermined conductivity used in electroporation of tissue
granted -
US 8153604
CNS-tumor treatment method and composition
granted -
US 8153620
Photoactive metal nitrosyls for blood pressure regulation and cancer therapy
granted -
US 8147833
Prevention and treatment of synucleinopathic and amyloidogenic disease
granted -
US 8148149
Methods of inducing tubulogenesis and/or branching morphogenesis of kidney cell cultures
granted -
US 8148328
Salicylanilides enhance oral delivery of therapeutic peptides
granted -
US 8148510
Antifungal polypeptides
granted -
US 8148352
Antimicrobial therapy for bacterial infections
granted -
US 8143295
Compounds having activity in correcting mutant-CFTR processing and uses thereof
granted -
US 8143226
Tyrosine kinase receptor antagonists and methods of treatment for breast cancer
granted -
US 8138310
Chimeric CD154 polypeptides
granted -
US 8133915
Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators
granted -
US 8133902
Ammosamides as anticancer agents
granted -
US 8129349
Treatment of disease by inducing cell apoptosis
granted -
US 8129334
Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
granted -
US 8129433
Enterically coated cysteamine, cystamine and derivatives thereof
granted -
US 8129335
Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
granted